戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and severity of neuropathy and the levels of very-long-chain 1-deoxyceramides such as C24 (P < 0.05),
2 romoter between the two human genes encoding very long chain acyl-CoA dehydrogenase (VLCAD) and posts
3 ferase, very long chain acyl-CoA synthetase, very long chain acyl-CoA dehydrogenase) in livers of the
4 re we provide evidence that in this organism very long chain acyl-CoA esters are hydrolyzed by the Px
5 raphy and demonstrated a 10-fold increase in very long chain acyl-CoA specific activity (C24:0/C16:0)
6 hibited markedly decreased expression of the very long chain acyl-CoA synthase-related gene (VLACSR),
7  cell extracts suggested that FATP1 exhibits very long chain acyl-CoA synthetase (ACS) activity and t
8  Members of the fatty acid transport protein/very long chain acyl-CoA synthetase (FATP/Acsvl) family
9                                          The very long chain acyl-CoA synthetase activity of the two
10       These results indicate that FATP1 is a very long chain acyl-CoA synthetase and suggest that a p
11 , liver carnitine palmitoyl-CoA transferase, very long chain acyl-CoA synthetase, very long chain acy
12 nthetase activity (C16:0), characteristic of very long chain acyl-CoA synthetases, whereas both mutan
13                 The 11 long-chain (ACSL) and very long chain acyl-coenzyme A (acyl-CoA) synthetases [
14 in skin homeostasis, which may be due to its very long chain acyl-coenzyme A synthetase activity.
15 t exogenous long-chain fatty acids, and have very long-chain acyl CoA synthetase activities that were
16                            The depression in very long-chain acyl CoA synthetase activities were not
17                                              Very long-chain acyl-CoA dehydrogenase (VLCAD) deficienc
18 though many patients have been found to have very long-chain acyl-CoA dehydrogenase (VLCAD) deficienc
19                                              Very long-chain acyl-CoA dehydrogenase (VLCAD) deficienc
20 long-chain acyl-CoA dehydrogenase (LCAD) and very long-chain acyl-CoA dehydrogenase revealed that 5-t
21 unsaturated acyl-CoAs are poor substrates of very long-chain acyl-CoA dehydrogenase when compared wit
22 , and deficiency of mitochondrial medium- or very long-chain acyl-CoA dehydrogenase.
23 ls suggest that, in contrast to yeast cells, very long-chain acyl-CoA esters are transported into per
24 s been associated with decreased peroxisomal very long-chain acyl-CoA synthetase (VLCS) activity and
25 creased VLCFA beta-oxidation and peroxisomal very long-chain acyl-CoA synthetase (VLCS) activity.
26     We reported previously that homolog 2 of very long-chain acyl-CoA synthetase (VLCS) can activate
27          LACS1 thus appears to function as a very long-chain acyl-CoA synthetase in wax metabolism.
28                           A human homolog of very long-chain acyl-CoA synthetase, hVLCS-H2, has two r
29 002 is a prodrug that requires activation by very long-chain acyl-CoA synthetase-1 (ACSVL1) to modula
30         The family of proteins that includes very long-chain acyl-CoA synthetases (ACSVL) consists of
31 fatty acid transport proteins (FATP) and the very long-chain acyl-CoA synthetases (VLACS).
32   The most recently identified family is the very long-chain acyl-CoA synthetases (VLCS).
33                              Other long- and very long-chain acyl-CoA synthetases were incapable of a
34                                              Very-long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes
35  specifically exhibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, w
36                                              Very-long-chain acyl-CoA dehydrogenase (VLCAD) is a majo
37                                              Very-long-chain acyl-CoA dehydrogenase (VLCAD) is a memb
38 trate specificity, it appears that ACAD9 and very-long-chain acyl-CoA dehydrogenase are unable to com
39                       In three patients with very-long-chain acyl-CoA dehydrogenase deficiency, this
40 istribution and gene regulation of ACAD9 and very-long-chain acyl-CoA dehydrogenase identify the pres
41                     Moreover, the FAO enzyme very-long-chain acyl-CoA dehydrogenase physically intera
42  function that is highly homologous to human very-long-chain acyl-CoA dehydrogenase was identified by
43 Gel filtration analysis indicated that, like very-long-chain acyl-CoA dehydrogenase, ACAD-9 is a dime
44                                   ACBP binds very-long-chain acyl-CoA esters, which is required for i
45                                 We generated very-long-chain acyl-coenzyme A dehydrogenase (VLCAD)-de
46  decreased ability of cells to activate (via very-long-chain acyl-coenzyme A synthetase [VLCS]) and s
47 ly hydrophobic compounds including saturated very-long-chain alkanes, ketones, and alcohols.
48            In summary, the CoA thioesters of very-long-chain and branched-chain fatty acids are much
49 ) is very similar to the multigene family of very long chain (C20-C26) acyl-CoA synthetases.
50                                              Very long chain (C22-C24) ceramides are synthesized by c
51  (N-palmitoyl sphingosine) and nonsaturated, very long chain C24:1 ceramide (N-nervonoyl sphingosine)
52 le of activating both long-chain (C16:0) and very long-chain (C24:0) fatty acids.
53 hat confluence caused selective increases in very long chain ceramide C(24:1) (370 +/- 54%) and C(24:
54  bases in blood, accompanied by increases in very long chain ceramide species, and have defective lym
55 d cellular levels of specific long-chain and very long-chain ceramide species relative to vector cont
56 nt with a significant reduction in long- and very-long-chain ceramide levels.
57 ivering a single dose of radiation, long and very-long-chain ceramide species, and the expression lev
58 f growth arrest on the increase in levels of very long chain ceramides.
59    Stress increased the amounts of long- and very long-chain ceramides in HEK293 cells, and this was
60           haCER1 catalyzed the hydrolysis of very long-chain ceramides to generate sphingosine (SPH).
61 terestingly, elevated levels of only certain very long-chain ceramides were evident in V5-aSMase(S508
62                                  Ablation of very-long-chain ceramides (Cers) with consecutive elevat
63 ication of several endogenous long-chain and very-long-chain ceramides using two nonphysiological odd
64 cluding C(24/25)-which are predominant among very-long-chain components.
65 s in the retina with special emphasis on the very-long-chain-containing saturated (VLC-FA) and polyun
66 the Gly-containing desaturase was capable of very-long-chain desaturation.
67                                    Typically very long chain diacetylene lipids formed gels in ethano
68 d seed coats with a severalfold reduction in very long chain dicarboxylic acid and omega-hydroxy fatt
69  carboxylase, inhibited only elongation into very long chain FAs (>or=20 carbons) but not synthesis o
70 ptor CD36 is required both for the uptake of very long chain FAs (VLCFAs) in cultured cells and the a
71                             The elongases of very long chain fatty acid (ELOVL or ELO) are essential
72 ed to provide insight into the regulation of very long chain fatty acid (VLCFA) biosynthesis in Brass
73 letion of ALD gene (ABCD1) and the resultant very long chain fatty acid (VLCFA) derangement has drama
74 roxisomal transmembrane protein required for very long chain fatty acid (VLCFA) metabolism.
75                         Utilizing the plasma very long chain fatty acid assay, supplemented by mutati
76 ese studies reveal roles for Rvs161p and the very long chain fatty acid elongase, Sur4p, in the local
77 sequence identity with previously identified very long chain fatty acid elongases.
78 ,3-enoyl-CoA reduction reactions in long and very long chain fatty acid elongation, respectively.
79 tly linked to the (omega-1)-hydroxy group of very long chain fatty acid in bradyrhizobial lipid A.
80 Although FATP4 deficiency primarily affected very long chain fatty acid metabolism, mutant fibroblast
81 etabolic pathways, ether lipid synthesis and very long chain fatty acid oxidation.
82 CoA synthetase that preferentially activates very long chain fatty acid substrates, such as C24:0, to
83 3-ketoacyl-CoA synthase which is involved in very long chain fatty acid synthesis in vegetative tissu
84 r C18:1, suggesting that in vivo, defects in very long chain fatty acid uptake may underlie the skin
85 oblasts, FATP4 is the major enzyme producing very long chain fatty acid-CoA for lipid metabolic pathw
86 the condensation of a long chain base with a very long chain fatty acid.
87  tachyzoites synthesized a range of long and very long chain fatty acids (C14:0-26:1).
88 cid elongases that catalyze the synthesis of very long chain fatty acids (C24 to C26) required for ce
89 n of VLCFA synthesizing enzymes, elongase of very long chain fatty acids (ELOVLs) (1 and 3) in both c
90  Abnormalities in the transport of saturated very long chain fatty acids (VLCFA; >C18:0) contribute t
91  adrenoleukodystrophy is the accumulation of very long chain fatty acids (VLCFAs) due to impaired per
92 lting in the inability to transport acylated very long chain fatty acids (VLCFAs) into the peroxisome
93 he bubblegum mutant shows elevated levels of very long chain fatty acids (VLCFAs), as seen in the hum
94                          The assay of plasma very long chain fatty acids (VLCFAs), developed in our l
95 id elongase required for the biosynthesis of very long chain fatty acids (VLCFAs).
96                                Elongation of very long chain fatty acids 4 (ELOVL4) is a novel member
97 ed in exon six of a gene named Elongation of very long chain fatty acids 4 (ELOVL4).
98 ed by mutations in the ELOVL4 (Elongation of very long chain fatty acids 4) gene.
99  receptor drives adults to convert lipids to very long chain fatty acids and hydrocarbons for an anti
100    Rather, dHNF4 directs their conversion to very long chain fatty acids and hydrocarbons, which wate
101                                          The very long chain fatty acids are crucial building blocks
102                               Degradation of very long chain fatty acids decreased by 47% and resulte
103 S), the enzyme responsible for production of very long chain fatty acids of plant seed oils.
104 miR-219 and its target ELOVL7 (elongation of very long chain fatty acids protein 7) were identified a
105                    In contrast, synthesis of very long chain fatty acids was primarily dependent on a
106 oil and fatty acid composition, accumulating Very Long Chain Fatty Acids with industrial applications
107  dehydratases are required for elongation of very long chain fatty acids, and HACD1 has a role in ear
108 lar endothelial cells causes accumulation of very long chain fatty acids, but much later than the imm
109                                     We found very long chain fatty acids, medium chain acylcarnitines
110                                Elongation of very long chain fatty acids-4 (ELOVL4) has been identifi
111  in the expression of the gene elongation of very long chain fatty acids-like 2, an enzyme needed for
112 ulin-induced gene 2a, Insig2a, elongation of very long chain fatty acids-like 3, Elovl3 and sterol 12
113     A Met299Val variant in the elongation of very long chain fatty acids-like 4 (ELOVL4) gene was sig
114 haracterized by the abnormal accumulation of very long chain fatty acids.
115 activity, with an apparent preference toward very long chain fatty acids.
116 ormalities in these cells are not limited to very long chain fatty acids.
117 gation of a second stearate molecule to form very long chain fatty acids.
118 active on long chain fatty acids relative to very long chain fatty acids.
119 nounsaturated fatty acids and a reduction in very long chain fatty acids.
120 saturases, enzymes involved in elongation of very long chain fatty acids.
121 roteins that function in the biosynthesis of very long chain fatty acids.
122 kodystrophy protein, with an accumulation of very long chain fatty acids.
123 TmELO2 function to synthesize long chain and very long chain fatty acids.
124 in the ABCD1 gene leading to accumulation of very long chain fatty acids.
125                            PpORS condenses a very long chain fatty acyl-CoA with four molecules of ma
126 ption mutant (DeltafoxA) was eliminated on a very long-chain fatty acid (C(22:1)), growth was only pa
127  classes on the stem and leaf, except in the very long-chain fatty acid (VLCFA) class wherein acids l
128  In this study, we investigated the roles of very long-chain fatty acid (VLCFA) synthesis by fatty ac
129  the elongase system of enzymes required for very long-chain fatty acid (VLCFA) synthesis.
130 nted the defects in fatty acid transport and very long-chain fatty acid activation associated with a
131         mBG1 appears to play a minor role in very long-chain fatty acid activation in these cells, in
132 transport protein 4 (FATP4), which each have very long-chain fatty acid acyl-CoA synthetase (VLCFA-AC
133 phingolipid pathway, such as deletion of the very long-chain fatty acid elongase, Sur4, suppress the
134                                              Very long-chain fatty acid levels were partially restore
135 other acyl-CoA synthetases are necessary for very long-chain fatty acid metabolism in Neuro2a cells.
136  and is capable of activating both long- and very long-chain fatty acid substrates.
137 f the ACC and elevation of the ceramides and very long-chain fatty acid syntheses with normal cell-cy
138  synthase that catalyzes the initial step of very long-chain fatty acid synthesis.
139 smembrane proteins that facilitate long- and very long-chain fatty acid uptake.
140 amily of six FATPs that facilitate long- and very long-chain fatty acid uptake.
141                   Mutations in elongation of very long-chain fatty acid-4 (ELOVL4) are associated wit
142 , which is responsible for the elongation of very long-chain fatty acids (at least 26 carbons).
143 ese cells are devoid of ABCD1 and accumulate very long-chain fatty acids (C26:0 and C26:1).
144  defect in synthesis of unsaturated long and very long-chain fatty acids (LCFAs and VLCFAs) and deple
145   Sphingolipids are synthesized de novo from very long-chain fatty acids (VLCFA) and sphingoid long-c
146 bers of this group are capable of activating very long-chain fatty acids (VLCFA), one is a bile acid-
147 ve disorder characterized by accumulation of very long-chain fatty acids (VLCFA).
148 re of X-ALD is increased levels of saturated very long-chain fatty acids (VLCFA; carbon chains of 22
149                                              Very long-chain fatty acids (VLCFAs) are essential lipid
150 present study, we found that the contents of very long-chain fatty acids (VLCFAs) in akr2a mutants we
151 (del/del) mice revealed a global decrease in very long-chain fatty acids (VLFAs) (i.e., carbon chain
152 X-ALD is characterized by an accumulation of very long-chain fatty acids and partially impaired perox
153 possibility that intermediate metabolites of very long-chain fatty acids and peroxisomal beta-oxidati
154 p and Elo3p are inviable confirming that the very long-chain fatty acids are essential for cellular f
155 tol-ceramides [IPC, MIPC, and M(IP)(2)C] and very long-chain fatty acids C(24) and C(26) declined sha
156 ssion pattern and ability of BG1 to activate very long-chain fatty acids implicates this enzyme in th
157 icantly inhibited the omega-hydroxylation of very long-chain fatty acids in cultured human keratinocy
158 rely impaired as degradation of unesterified very long-chain fatty acids in X-ALD and is abolished in
159 ferentiation: ELOVL1, encoding elongation of very long-chain fatty acids protein 1, and SLC27A1, enco
160                            Mycolic acids are very long-chain fatty acids representing essential compo
161       Major cuticular wax compounds, such as very long-chain fatty acids, alcohols, alkanes, and keto
162  and Elo3p are required for synthesis of the very long-chain fatty acids, and mutants lacking both El
163 of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower i
164 l membrane proteins involved in transport of very long-chain fatty acids, which are a unique componen
165 NA library, we have identified elongation of very long-chain fatty acids-like 1 (ELOVL1) and fatty ac
166 nd C24:0 as substrates), and accumulation of very long-chain fatty acids.
167 xogenous fatty acids or in the activation of very long-chain fatty acids.
168 t-chain and severely restricted on long- and very long-chain fatty acids.
169 long-chain fatty acids and the activation of very long-chain fatty acids; these activities intrinsic
170 ble exceptions, the fatty acid transport and very long-chain fatty acyl-CoA synthetase activities wer
171 ates, the levels of fatty acid accumulation, very long-chain fatty acyl-CoA synthetase activities, an
172  coenzyme A derivatives using long-chain and very-long chain fatty acids, bile acids and bile acid pr
173 ts, led us to discover that BacA affects the very-long-chain fatty acid (27-OHC28:0 and 29-OHC30:0) c
174           We showed that NLMs lost saturated very-long-chain fatty acid (FA; C24:0) SM in cancer cell
175 es the first and rate-limiting enzyme of the very-long-chain fatty acid (VLCFA) beta-oxidation pathwa
176 and Schefflera elegantissima) contained only very-long-chain fatty acid (VLCFA) derivatives such as a
177                          Notably, an unusual very-long-chain fatty acid (VLCFA) is found in the lipid
178 chological, electrophysiological, and plasma very-long-chain fatty acid (VLCFA) measurements were use
179 se complex are required for the synthesis of very-long-chain fatty acid (VLCFA) precursors of cuticul
180 reviously undescribed desaturase activity on very-long-chain fatty acid (VLCFA) substrates and exhibi
181 slation initiation factor 2B (eIF2B) and the very-long-chain fatty acid (VLCFA) synthesis keto-reduct
182 ase type 12 (HSD17B12) as a human hub of the very-long-chain fatty acid (VLCFA) synthesis pathway and
183 CS2), which catalyze two successive steps in very-long-chain fatty acid (VLCFA) synthesis.
184 and B. abortus are unusually modified with a very-long-chain fatty acid (VLCFA; C > or = 28) and we d
185 ectrometry (LC/MS) method for long-chain and very-long-chain fatty acid analysis and its application
186 not ZS, fibroblasts there was an increase in very-long-chain fatty acid beta-oxidation and plasmaloge
187  X-ALD fibroblasts synergistically increased very-long-chain fatty acid beta-oxidation, indicating th
188 lasmalogen concentrations, and a decrease in very-long-chain fatty acid concentrations.
189 drenoleukodystrophy (X-ALD) is a disorder of very-long-chain fatty acid metabolism, adrenal insuffici
190                                 Reduction of very-long-chain fatty acid sphingolipid levels leads in
191 results in an increase in phospholipids with very-long-chain fatty acid tails (PL-VLCFAs) that contai
192 distribution of LPS fatty acids, including a very-long-chain fatty acid thought to be unique to the a
193 amily of six FATPs that facilitate long- and very-long-chain fatty acid uptake.
194 he PM showed an enrichment of 2-hydroxylated very-long-chain fatty acid-containing GIPCs and polyglyc
195 ision, suggesting that enhanced synthesis of very-long-chain fatty acid/trihydroxy LCB ceramides prom
196  Individuals with ABCD1 mutations accumulate very-long-chain fatty acids (VLCFA) (carbon length >22).
197                                              Very-long-chain fatty acids (VLCFA) and branched-chain f
198 X-ALD) is associated with elevated levels of very-long-chain fatty acids (VLCFA; C(>22:0)) that have
199                               Long-chain and very-long-chain fatty acids (VLCFAs) are also metabolize
200                     Among lipid species, the very-long-chain fatty acids (VLCFAs) are relatively rare
201                             The extension of very-long-chain fatty acids (VLCFAs) for the synthesis o
202    TSC13 is required for the biosynthesis of very-long-chain fatty acids (VLCFAs) in yeast.
203  which exacerbates accumulation of LCFAs and very-long-chain fatty acids (VLCFAs) that mediate lipoto
204 ce blast fungus Magnaporthe oryzae, requires very-long-chain fatty acids (VLCFAs), which act as media
205 , including fatty acid elongation to produce very-long-chain fatty acids (VLCFAs).
206 des accumulation of peroxisomal educts (like very-long-chain fatty acids [VLCFAs] or branched-chain f
207 flammatory demyelination in the brain, where very-long-chain fatty acids accumulate within phospholip
208 1/lpcat2 mutant showed increased contents of very-long-chain fatty acids and decreased PUFA in TAG an
209 lopmental and environmental requirements for very-long-chain fatty acids and flavonoids, whose synthe
210 ACC (ScACC) is crucial for the production of very-long-chain fatty acids and the maintenance of the n
211    This led to a significant increase in the very-long-chain fatty acids C24 and C26 in the cuticular
212  synthetase [VLCS]) and subsequently degrade very-long-chain fatty acids in peroxisomes.
213 n GIPCs and sterols and suggested a role for very-long-chain fatty acids in the interdigitation betwe
214  mutations in ABCD1 lead to incorporation of very-long-chain fatty acids into phospholipids, we separ
215 litate the transfer of long-chain as well as very-long-chain fatty acids into the apoplast, depending
216                       Our findings implicate very-long-chain fatty acids or their derivative complex
217 ein, required for the efficient transport of very-long-chain fatty acids out of the cytoplasm.
218  have shown that larval oenocytes synthesize very-long-chain fatty acids required for tracheal waterp
219 an acyl CoA synthetase activity specific for very-long-chain fatty acids suggesting this protein play
220  (CER6) is necessary for the biosynthesis of very-long-chain fatty acids with chain lengths beyond C(
221  mutations in the ELOVL4 gene (elongation of very-long-chain fatty acids).
222 of Elovl proteins that mediate elongation of very-long-chain fatty acids, block or dramatically slow
223      In a yeast strain engineered to produce very-long-chain fatty acids, CER1-LIKE1 interacted with
224 ngation of not only linear but also branched very-long-chain fatty acids, leading to production of th
225 n cause accumulation of unbranched saturated very-long-chain fatty acids, particularly in brain and a
226 pecies with C16 fatty acids rather than with very-long-chain fatty acids, which are more commonly enr
227 ndensing enzyme involved in the synthesis of very-long-chain fatty acids, which are precursors of epi
228 ng patterns of saturated and monounsaturated very-long-chain fatty acids, with the observed pattern c
229 ingle allelic mutations in the elongation of very-long-chain fatty acids-like 4 (ELOVL4), whereas rec
230 long-chain fatty acids and the activation of very-long-chain fatty acids.
231 ber of genes involved in the biosynthesis of very-long-chain fatty acids.
232 hase--an enzyme involved in the synthesis of very-long-chain fatty acids.
233  showed that AtLtpI-4 protein can bind these very-long-chain fatty acids.
234 tent, with some molecular species containing very-long-chain fatty acids.
235   We also investigated two distantly related very-long-chain fatty acyl (VLCFA) desaturases from Arab
236 3 (At1g19260)-encoded ceramide synthases use very-long-chain fatty acyl-CoA and trihydroxy LCB substr
237 oxidation chain shortening of long-chain and very-long-chain fatty acyl-coenzyme (CoAs), long-chain d
238 vity of class II ceramide synthases that use very-long-chain fatty acyl-coenzyme A and trihydroxy LCB
239 t jojoba FAO and FADH proteins are active on very-long-chain fatty alcohol and fatty aldehyde substra
240 gest that jojoba FAO and FADH constitute the very-long-chain fatty alcohol oxidation pathway that is
241     Upon germination, WE hydrolysis releases very-long-chain fatty alcohols, which must be oxidized t
242 ax profile (especially on leaves) toward the very-long-chain free fatty acids tetracosanoic acid (C(2
243 pressed in photoreceptor cells and generates very long chain (&gt;/=C28) polyunsaturated fatty acids inc
244 ancer suggest that 1-deoxysphingolipids, the very-long-chain in particular, play a role as molecular
245 istics suggest that it may interact with the very long chain intermediates in mycolic acid biosynthes
246 he other hand, was missing O-antigens of the very long chain length, indicating the Wzz2 protein is r
247 ed with other fatty acids and because of its very long chain length, the effect of dietary behenic ac
248  responsible for the expression of different very long chain lengths despite high sequence homology.
249 out for long chain palmitic acid (C16:0) and very long chain lignoceric acid (C24:0) as well as for A
250 ut for long chain (palmitic acid, C16:0) and very long chain (lignoceric acid, C24:0) fatty acids as
251  suppressor demonstrates that low amounts of very long chain lipids are sufficient for pollen hydrati
252                                              Very long chain lipids contribute to the hydrophobic cut
253 Mutations in Arabidopsis CER genes eliminate very long chain lipids from the cuticle surface and, in
254 e display massive increases in a rare set of very long chain LPS lipids that have been previously rep
255 he N-acyl chains showed a high occurrence of very-long-chain moieties; phytosphingosine and 4-hydroxy
256      Cuticular wax is a mixture of aliphatic very-long-chain molecules, ranging from 22 to 48 carbons
257 NA bases influences the global properties of very-long-chain molecules.
258 and a dramatic increase in the percentage of very-long-chain monounsaturated fatty acids in the acyl-
259  whether red blood cell (RBC) long-chain and very-long-chain MUFAs are associated with risk of CAD in
260 c and lipotoxicity effects of long-chain and very-long-chain MUFAs on cardiomyocytes.
261                               Therefore, the very long chain n-3 PUFAs in eggs were protected from un
262                    Proportions of n-3 PUFAs (very long-chain n-3 [VLC n-3; sum of eicosapentaenoic ac
263 f refrigerated stored hen eggs enriched with very long-chain n-3 fatty acids, was investigated.
264    Higher proportions of certain VLC n-3 and very long-chain n-6 PUFAs in plasma phospholipids at age
265 he effect and the mechanism of action of the very-long-chain n-3 (omega-3) polyunsaturated fatty acid
266                      Serum linoleic acid and very-long-chain n-3 PUFAs, partly reflecting vegetable o
267 feasibility for CEC-ESI-MS analysis of these very long chain nonionic surfactants for the first time.
268  in place of the proximal glucosamine, and a very long chain omega-1 hydroxy fatty acid, 27-hydroxyoc
269  ELONGASE1 is required for the production of very long chain omega-7s in the aleurone.
270 function.We tested the effects of high-dose, very-long-chain omega-3 fatty acids on adipose tissue in
271                                              Very long chain polyunsaturated fatty acid (VLC-PUFA)-co
272 e activity and approximately 40% decrease in very long chain polyunsaturated fatty acid chain shorten
273 is therefore a key step in the production of very long chain polyunsaturated fatty acid in oil-seed s
274 aturated fatty acids (VLC-FA) and of C28-C38 very long chain polyunsaturated fatty acids (VLC-PUFA),
275 nsiderable beneficial effects of n-3 and n-6 very long chain polyunsaturated fatty acids (VLC-PUFAs),
276              We report the production of two very long chain polyunsaturated fatty acids, arachidonic
277 duction of phospholipids containing 22:6 and very long-chain polyunsaturated fatty acids (VLC-PUFAs)
278 an elongase required for the biosynthesis of very long-chain polyunsaturated fatty acids (VLC-PUFAs).
279 ptor-specific phosphatidylcholine containing very long-chain polyunsaturated fatty acids and severely
280 nthesized in the stroma, then converted into very-long-chain polyunsaturated fatty acids (FAs) at the
281  acid, as well as decreased incorporation of very-long-chain polyunsaturated fatty acids (PUFAs), par
282 mal models clearly indicates that a group of very-long-chain polyunsaturated fatty acids, the n-3 fat
283  of peroxisomes in the oxidation of complex, very long chain, polyunsaturated fatty acids.
284 etion may prevent the conversion of ALA into very-long-chain PUFAs.
285 enrichment in sterols and sphingolipids with very long chain saturated fatty acids when compared with
286  an oxidase required for the biosynthesis of very-long-chain saturated alpha,omega-bifunctional aliph
287 (DNL) FAs and low n-6 (omega-6) FAs, 2) high very-long-chain saturated FAs, 3) high n-3 (omega-3) FAs
288                                  Circulating very-long-chain saturated fatty acids (VLCSFAs) may play
289 id, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrat
290 lly expressed in Arabidopsis, GPAT5 produced very-long-chain saturated monoacylglycerols and free fat
291 6-ceramide, which occurred at the expense of very long chain, saturated ceramides.
292 tions that enable a switch between long- and very-long-chain selectivity.
293 hat higher circulating concentrations of the very-long-chain SFAs (VLSFAs) arachidic acid (20:0), beh
294                                              Very-long-chain SFAs (VLSFAs) have recently gained consi
295 16:0) are associated with diabetes; however, very-long-chain SFAs (VLSFAs), with 20 or more carbons,
296 llowed by the more challenging separation of very long chain TX-series with a large number (n = 30-70
297 nsation reaction catalyzing the formation of very-long-chain (VLC) (C-28 to C-40) fatty acids, satura
298                              In land plants, very-long-chain (VLC) alkanes are major components of cu
299 id bilayer, facilitating the desaturation of very-long-chain (VLC) substrates.
300 cates that AD1 functions in the formation of very-long-chain wax components.

 
Page Top